Cogent Biosciences, Inc.
COGT
Classement en actions
#3346
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted... Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.
Prix de l'action
$30.00
Capitalisation boursière
$5.21B
Changement (1 jour)
1.63%
Changement (1 an)
83.04%
Pays
US
Échange Cogent Biosciences, Inc. (COGT)
Catégorie
Healthcare
EPS pour Cogent Biosciences, Inc. (COGT)
EPS au June 2026 TTM : $-2.31
Selon les derniers rapports financiers et le cours de l'action de Cogent Biosciences, Inc., l’EPS actuel de la société (TTM) est de $-2.31. À la fin de 2023, la société avait un EPS de $-2.42 une augmentation par rapport à celui de 2022, qui était de $-2.26.
Historique de l'EPS de Cogent Biosciences, Inc. de 2015 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2026 (TTM) | $-2.31 | -6.10% |
| 2024 | $-2.46 | 1.65% |
| 2023 | $-2.42 | 7.08% |
| 2022 | $-2.26 | 22.16% |
| 2021 | $-1.85 | -69.17% |
| 2020 | $-6.00 | 51.13% |
| 2019 | $-3.97 | -28.47% |
| 2018 | $-5.55 | 60.87% |
| 2017 | $-3.45 | 11.29% |
| 2016 | $-3.10 | 174.34% |
| 2015 | $-1.13 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| $17.32 | -849.78% |
US
|
|
| $-7.98 | 245.45% |
US
|
|
| $-5.29 | 129.00% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -1,300.87% |
NL
|
